Narrative Metabolic reprogramming by oncogenes and tumor suppressors has a central role in the initiation and progression of cancers, including high-risk neuroblastoma. In this application, we will investigate a new mechanism by which the oncogene MYCN integrates cholesterol synthesis with nucleotide and amino acid metabolism, which may suggest new therapeutic strategies against this deadly pediatric cancer.
- National Cancer Institute: $352,275.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.